Cargando…

Medicare's prescription drug program : competition issues and cost trends /

The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (generally referred to as the Medicare Modernization Act, or MMA) substantially expanded the federal Medicare program by creating the prescription drug benefit known as Part D. In fiscal year 2013, Medicare Part D covered 39...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Pattinson, Gloria R. (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: New York : Nova Publishers, [2014]
Colección:Health care in transition series.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 i 4500
001 EBSCO_ocn894666750
003 OCoLC
005 20231017213018.0
006 m o d
007 cr |||||||||||
008 150210s2014 nyua ob 001 0 eng
010 |a  2020676824 
040 |a DLC  |b eng  |e rda  |e pn  |c DLC  |d N$T  |d E7B  |d YDXCP  |d OCLCF  |d EBLCP  |d DEBSZ  |d AGLDB  |d VTS  |d STF  |d M8D  |d OCLCO  |d OCLCQ  |d OCLCO 
019 |a 914433370  |a 923677002  |a 928196491 
020 |a 9781634631532  |q (ebook) 
020 |a 1634631536 
020 |z 1634631226  |q (hbk.) 
020 |z 9781634631228  |q (hbk.) 
029 1 |a AU@  |b 000054572933 
029 1 |a DEBBG  |b BV043783410 
029 1 |a DEBSZ  |b 456589333 
029 1 |a DEBSZ  |b 472853813 
035 |a (OCoLC)894666750  |z (OCoLC)914433370  |z (OCoLC)923677002  |z (OCoLC)928196491 
043 |a n-us--- 
050 4 |a RA412.3 
072 7 |a BUS  |x 033070  |2 bisacsh 
082 0 4 |a 368.42600973  |2 23 
049 |a UAMI 
245 0 0 |a Medicare's prescription drug program :  |b competition issues and cost trends /  |c Gloria R. Pattinson, editor. 
264 1 |a New York :  |b Nova Publishers,  |c [2014] 
300 |a 1 online resource 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Health care in transition 
500 |a Includes index. 
588 0 |a Print version record. 
505 0 |a MEDICARE'S PRESCRIPTION DRUG PROGRAM: COMPETITION ISSUES AND COST TRENDS; MEDICARE'S PRESCRIPTION DRUG PROGRAM: COMPETITION ISSUES AND COST TRENDS; Library of Congress Cataloging-in-Publication Data; CONTENTS; PREFACE; Chapter 1: COMPETITION AND THE COST OF MEDICARE'S PRESCRIPTION DRUG PROGRAM; SUMMARY; SECTION 1. THE FEDERAL BUDGETARY COST OF MEDICARE PART D; SECTION 2. THE COMPETITIVE DESIGN OF MEDICARE PART D; SECTION 3. COMPARING MEDICARE PART D AND MEDICAID FEE FOR SERVICE. 
505 8 |a APPENDIX A. CALCULATING THE FEDERAL GOVERNMENT'S PAYMENTS AND BENEFICIARIES' COST-SHARING AMOUNTS FOR MEDICARE PART DAPPENDIX B. COMPARING THE USE AND PRICES OF DRUGS IN MEDICARE PART D AND MEDICAID FEE FOR SERVICE; Chapter 2: EFFECTS OF USING GENERIC DRUGS ON MEDICARE'S PRESCRIPTION DRUG SPENDING; SUMMARY; BOX 1. GENERIC DRUGS IN THE U.S. PHARMACEUTICAL MARKETPLACE; BOX 2. HOW COMPETITION FROM GENERIC DRUGS AFFECTS PRICES AND QUANTITIES OF PRESCRIPTION DRUGS; APPENDIX: DESCRIPTION OF DATA USED IN THIS ANALYSIS; Chapter 3: SPENDING PATTERNS FOR PRESCRIPTION DRUGS UNDER MEDICARE PART D. 
505 8 |a The medicare part d programnon-lis beneficiaries; part d insurance plans and the standard benefit; distribution of spending among non-lis beneficiaries; drivers of higher spending among non-lis beneficiaries; the federal contribution to part d spending for non-lis beneficiaries; implications of recent health care legislation for non-lis beneficiaries; lis beneficiaries; the federal contribution to spending for lis beneficiaries; comparing non-lis and lis beneficiaries; index. 
520 |a The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (generally referred to as the Medicare Modernization Act, or MMA) substantially expanded the federal Medicare program by creating the prescription drug benefit known as Part D. In fiscal year 2013, Medicare Part D covered 39 million people. The federal government spent 59 billion net of premiums on Part D in that year; after accounting for certain payments from states under the program, the net federal cost was 50 billion, which represented 10 percent of net federal spending for Medicare. This book discusses the cost tr. 
590 |a eBooks on EBSCOhost  |b EBSCO eBook Subscription Academic Collection - Worldwide 
650 0 |a Medicare. 
650 0 |a Pharmaceutical services insurance  |z United States. 
650 0 |a Medical care, Cost of  |z United States. 
650 2 |a Medicare 
650 6 |a Medicare. 
650 6 |a Assurance-médicaments  |z États-Unis. 
650 6 |a Soins médicaux  |x Coût  |z États-Unis. 
650 7 |a BUSINESS & ECONOMICS  |x Insurance  |x Risk Assessment & Management.  |2 bisacsh 
650 7 |a Medical care, Cost of  |2 fast 
650 7 |a Medicare  |2 fast 
650 7 |a Pharmaceutical services insurance  |2 fast 
651 7 |a United States  |2 fast 
700 1 |a Pattinson, Gloria R.,  |e editor. 
776 0 8 |i Print version:  |t Medicare's prescription drug program.  |d New York : Nova Publishers, [2014]  |z 9781634631228  |w (DLC) 2014498680 
830 0 |a Health care in transition series. 
856 4 0 |u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=886263  |z Texto completo 
938 |a ProQuest Ebook Central  |b EBLB  |n EBL2097190 
938 |a ebrary  |b EBRY  |n ebr10964975 
938 |a EBSCOhost  |b EBSC  |n 886263 
938 |a YBP Library Services  |b YANK  |n 12073446 
994 |a 92  |b IZTAP